1231 pages, $159Bramah N.SinghVictor JDzauPaul M.VanhoutteRaymond L.WoosleyCardiovascular pharmacology and therapeutics1994Churchill LivingstoneNew York  by Miller, Virginia & Barber, Dustan A.
BOOK REVIEWS 
John M. Porter, MD, Book Review Section Editor 
Vascular pathology 
W. E. Stehbens and J. T. Lie, London, 1995, Chapman 
& Hall Medical, 797 pages, $169. 
This is an encyclopedic work compiled by two 
pathologists; W. E. Stehbens, Professor Emeritus of Pa- 
thology, New Zealand School of Medicine and Malaghan 
Institute of Pathology, Wellington, New Zealand, and J. T. 
Lie, Department of Pathology, University of California, 
Davis, California. This volume, written in collaboration 
with 23 pathologists from around the world, attempts to 
fill a gap that previously existed in the libraries of physicians 
managing vascular disease. 
In a systematic and complete fashion, the text covers 
pathology, hemodynamics, congenital anomalies, bio- 
chemical and metabolic disorders, atherosclerosis, and 
other vascular diseases. The information in this 785-page 
book is presented concisely and in an easily accessible 
manner. The photographs and illustrations are used 
appropriately and contribute to the explanation of the text. 
The list of references for each chapter is complete, and 
current vascular literature is cited. 
Some of the chapters in this book should be required 
reading, especially "Connective tissue components of the 
blood vessel wall in health and disease" by S. Robins and 
C. Farquharson, and "Biochemistry and cell biology of 
atherogenesis" byH. F. Hoff. Other chapters that are likely 
to be valuable are ~'Neoplasms of the large blood vessels and 
tumor angiogenesis" and "Tumors and tumefactions of the 
peripheral blood vessels." 
As can be expected in the first volume of an ambitious 
project, there are some deficiencies. A chapter on the 
embryology of the cardiovascular system leading to a 
discussion of congenital defects in the vascular tree would 
have been welcome. There is only one paragraph on the 
pathology of radiation arteritis, and it is misplaced in the 
index. I am sure the editors will take note of these 
deficiencies and omissions in the next volume. 
This book is a timely contribution to the vascular 
disease knowledge base and will quickly become adefinitive 
reference text. I highly recommend it to anyone who is 
seeking a compendium of data and references on vascular 
pathology for his or her shelves. 
Sushil Gupta, M_D 
MetroWest Medical Center 
Framingham, Mass. 
Cardiovascular pharmacology and therapeutics 
Bramah N. Singh, Victor J. Dzau, Paul M. Vanhoutte, 
and Raymond L. Woosley, New York, 1994, Churchill 
Livingstone, 1231 pages, $159. 
Cardiovascular Pharmacology and Therapeutics was cre- 
ated to meet the need for a specialized text of drugs used 
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in the treatment of cardiovascular disease. This need has 
resulted from the rapid development of new drugs and the 
need for redefining established regimens of therapeutic 
intervention in the setting of the changing health care 
environment. As the editors intend, the book provides a 
rationale for the use of cardiovascular d ugs on the basis of 
results of basic research and clinical trials. The editors 
brought ogether an international group of basic scientists, 
clinicians, and clinical investigators expert in therapeutic 
intervention for cardiovascular disease, The text is well 
written, the illustrations are informative, the references are 
current, and subject index is extensive. There are three 
major conceptual sections of the text, each of which 
contains eparate subtopics and chapters. The first section 
is an excellent review of basic pharmacologic principles. 
These early chapters provide the necessary introduction to 
clinical and research aspects of pharmacology including 
pharmacokinetics. A chapter devoted to basic concepts of 
gene therapy is a topic not usually found in textbooks of 
pharmacology. This chapter provides an easy-to-follow 
summary of current echniques as they apply to cardiovas- 
cular physiology. Another unique chapter discusses design 
and statistical evaluation of clinical trials. This chapter 
should be useful to clinical residents and internists inter- 
ested in initiating clinical studies. 
The second major section of the book reviews 20 classes 
of drugs currently used in therapeutic management of 
cardiovascular disease. The chapters, in general, are short, 
comprehensive, and up-to-date. These chapters erve as a 
strong support and reference for later chapters dealing with 
cardiovascular diseases. A reasonable ffort was made to 
introduce new drugs and therapeutic strategies, including 
one short chapter devoted to novel biochemicals such as 
growth factors and adhesion molecules. 
The third major section of the book is organized 
according to major cardiovascular disorders including 
myocardial ischemia, infarctions and arrhythmias, conges- 
tive heart failure, hypertension, antithrombotic therapy, 
dyslipidemias and atherosclerosis,'and heart transplanta- 
tion. Some overlap with previous chapters is encountered 
in the evaluation of therapeutic intervention. However, 
because it is unlikely that the book would be read in direct 
sequence, the overlap is acceptable. For example, these 
sections could be used for assigned readings for discussion, 
review and teaching of medical and graduate students, and 
resident raining. Throughout hese sections, some con- 
sideration is given to evaluate clinical data as they relate to 
reduction in mortality rates. 
In addition to the chapters devoted to design of clinical 
trials and gene therapy, another unique feature of the text 
is chapters dealing with specialized cardiovascular therapies 
for pediatric, geriatric, and pregnant patients. Other demo- 
graphic considerations of sex and race are also considered. 
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These are important topics for therapeutic strategies 
because pidemiologically targeted rug therapies to de- 
mographic profiles such as race may be attractive for 
agencies disbursing limited health care dollars. However, as 
the author of this chapter points out, genetic expression of 
disease and efficacy of drugs may not be the same in people 
of the same identifiable phenotypic marker such as skin 
color. These chapters are excellent additions and provide 
information that is often difficult to find in comprehensive 
textbooks of pharmacology. Two appendixed tables also 
provide easy reference for changes in pharmacokinetics of 
common cardiovascular d ugs in the elderly and common 
adverse interactions involving cardiovascular d ugs. 
In spite of the comprehensive nature of the book, there 
are no sections related to therapeutic interventions for 
venous and lymphatic disease. This may reflect he lack of 
availability of efficacious pharmacologic therapy for these 
diseases in the United States. 
In summary, this is an up-to-date text of the current 
strategies for treatment of common cardiovascular disor- 
ders. The book should be a valuable reference not only for 
the cardiologists and internists, but also for family practi- 
tioners and surgeons who deal with aspects of cardiovas- 
cular medicine in their practice. Basic scientists will find the 
text useful for understanding clinical problems and strate- 
gies for therapeutic interventions for cardiovascular dis- 
eases. 
Vi~inia ~Iiller, PbD 
Dustan A. Barber, RPb, PbD 
Mayo Clinic 
Rochester, Minn. 
Reperfusion injuries and clinical capillary 
leak syndrome 
B. A. Zikria, et al., Armonk, N.Y., 1994, Futura 
Publishing Co., 617 pages, $85. 
The authors propose a clinical capillary leak syndrome 
as the unifying hypothesis between ischemia-reperfusion 
scenarios. This is highlighted in the chapters authored by 
Dr. Zikria. Subsections include endothelium, basic prin- 
ciples, clinical reperfusion syndromes, transplanta- 
tion, multiple organ failure (MOF), and finally future 
horizons. 
The author notes difficulty in finding the term "clinical 
capillary leak syndrome" in the medical literature and hopes 
to broaden its usage; apparently the term has been used to 
describe a clinical picture similar to MOF in patients 
undergoing chemotherapy. A "biophysical" (as opposed to 
biochemical) approach to these syndromes is proposed, 
along with therapy derived from this approach. They have 
used large molecules of starch in an effort to "seal" or 
"plug" the leaky sites. The authors' definition of clinical 
capillary leak syndrome (p. 472) is unfortunate: "Clinical 
capillary leak syndrome is often observed in patients who, 
following shock. . ,  demonstrate a state of generalized 
leaky capillaries." Absence of objective criteria is empha- 
sized by use of nonquantitative modifiers uch as general- 
ized, decreased, and possible to characterize the syndrome 
beyond kidney and lung failure. 
A distinguished group of collaborators contribute 
detailed information ranging from anatomic consider- 
ations to emerging molecular models. The initial sections 
review information ot acquired uring the usual course of 
medical and surgical training. These contributions are 
extensively referenced. A problem hindering the study of 
ischemia-reperfusion injury has been the relatively slow 
translation of research findings to clinical practice. In 
contrast, with transplantation, intervention before the 
ischemic insult has produced major improvements in organ 
preservation. MOF, like ischemia-reperfusion, is treated 
after recognition of the physiologic derangement. Accord- 
ing to Dr. Zikria, the promise of immunotherapy is largely 
unfulfilled despite rapid identification of specific agents and 
recombinant antisera. The ineffectiveness of single-agent 
interventions suggests a need for multiagent rials, or a 
completely different approach. 
The last chapter describes the use of Hespan and 
Pentastarch in the clinical capillary leak syndromes. Al- 
though there are encouraging experimental data to support 
further investigation, the authors have only begun to fulfill 
the promise of this therapy. If "capillary plugging" were 
capable of functional tissue preservation despite ndothelial 
injury, further investigation of this approach would be 
exciting. Does "plugging" improve cellular oxygen utiliza- 
tion? Does controlling edema alter outcome of ischemia- 
reperfusion injury or MOF? 
The physical presentation of this book is marred by an 
insertion sheet correcting adiagram (p. 99) and separation 
of the back end paper. Although the latter may be 
attributed to postal mishandling, the former was a major 
annoyance. In summary, the text offers detailed and topical 
reviews and may serve as a good starting point for 
developing a knowledge base in fluid management, mem- 
brane permeability, and clinical reperfusion syndromes. 
The suggestion and promise of "pore plugging" may 
represent a fertile field for further investigations. For these 
selected groups purchase of this text may provide a valuable 
summary of knowledge in this field. 
Frank Padberg, Jr., MD 
VA Medical Center 
East Orange, N.J. 
Aneurysm surgery 
I. Faris and B. Buxton, Edinburgh, 1995, Churchill 
Livingstone, 282 pages, $185. 
Aneurysm surgery is central to the practice of vascular 
surgery, and this book is a welcome addition to  the 
ever-growing library of vascular literature. Two primary 
contributors have illustrated the major procedures per- 
formed to treat arterial aneurysms. The subject content 
begins with perioperative management and progresses 
rapidly to thoracic, thoracoabdominal, bdominal, lower 
extremity, renal, and visceral aneurysms. Thoughtful dis- 
cussion of inflammatory, infected, and false aneurysms, as 
